Sentences with phrase «sharing amounts by»

For a similar family plan through Liberty HealthShare, you'd be paying $ 449 a month (or less — in addition to «units,» Liberty divides sharing amounts by age) and $ 1,500 that you're responsible for annually.

Sharing amounts by ratio 7.

Not exact matches

Canada's share declined by a similar amount, while the Mexican share of value - added increased to 13 per cent from 7.4 per cent.

When there are multiple claimants, the reward will be shared in amounts determined by Razer.

The Huffington Post shared the results of a new report by the Deloitte Center for Financial Services that predicted the number of U.S. millionaire households is expected to reach 20.6 million by 2020, nearly double the current amount.

Co-founded by Peter Sunde, who also co-founded the notorious Pirate Bay file - sharing site, it's a «social payment service» that lets people donate a fixed amount each month that then gets split up between the online services they want to support — kind of like a tip jar.

The valuation in the next cell is simple math: Divide the amount of investment by the share offered, and you get the implied valuation.

Changes to Facebook's news feed as part of an initiative to crack down on the share of low - quality viral videos reduced the amount of time users spend on the network by 50 million hours a day in the fourth quarter, the company reports.

The companies failed in a previous attempt to merge in 2015, and since then Tabcorp's shares have gained 11.4 % while Tatts has fallen by the same amount.

But a CEO selling large amounts of shares in a company is sometimes viewed as a lack of confidence by investors.

Restructuring charges are expected to reduce fourth quarter earnings by $ 0.15 to $ 0.16 per share, amounting to $ 155 to $ 165 million.

Under questioning by MPs, Sherman said by video link from California that it's possible a «small amount» of users» private messages may have also been inappropriately shared as part of the breach, without their consent.

Instead, Facebook's PR team and lower ranking leaders have led the company's defense by drawing technical distinctions between what happened and more common breaches by hackers, and by pointing out that Facebook curtailed the amount of user data it shared with app makers in 2014.

In other words, earnings per share have been boosted by a shrinking denominator — the amount of shares outstanding.

Adjusted earnings amounted to $ 1.38 per share, beating analyst estimates by six cents, according to a survey by Thomson Reuters.

The company most recently sold its Argentina wine business to Grupo Penaflor for an undisclosed amount, and earlier this year, speculation of a potential takeover by billionaire Jorge Paulo Lemann gave Diageo a nice share boost.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Except as expressly provided in the Plan, no issuance by Google of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number of shares or amount of other property subject to, or the terms related to, any Incentive Award.

Except as expressly provided in the Plan, no issuance by Alphabet of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number of shares or amount of other property subject to, or the terms related to, any Incentive Award.

If the participant sells the ISO shares prior to the expiration of these holding periods, the participant recognizes ordinary income at the time of disposition equal to the excess if any, of the lesser of (1) the aggregate fair market value of the ISO shares at the date of exercise and (2) the amount received for the ISO shares, over the aggregate exercise price previously paid by the participant.

Unless otherwise expressly provided in (or pursuant to) this Section 4 (c) or required by Applicable Law: (A) all Awards are non-transferable and shall not be subject in any manner to sale, transfer, anticipation, alienation, assignment, pledge, encumbrance or charge; (B) Awards that are Options or Stock Appreciation Rights shall be exercised only by the Participant; and (C) amounts payable or Shares issuable pursuant to any Award shall be delivered only to (or for the account of) the Participant.

The goal is to buy and sell these shares and to accumulate a greater amount of money than the other players by the game's end.

Any gain or loss recognized on such a premature disposition of the ISO shares in excess of the amount treated as ordinary income is treated as long - term or short - term capital gain or loss, depending on how long the shares were held by the participant prior to the sale.

The maximum amount of cash to be paid by Loblaw will be approximately $ 6.7 billion and the maximum number of Loblaw common shares to be issued will be approximately 119.9 million, based on the fully diluted number of Shoppers Drug Mart shares outstanding.

For purposes of the offering in Canada, if all of the shares have not been sold, after the Canadian underwriters have made a reasonable effort to sell the shares at the public offer price, the Canadian underwriters may from time to time decrease or change the offering price and the other selling terms provided that the price for the shares shall not exceed the public offer price and further provided that the compensation that is realized by the Canadian underwriters will be decreased by the amount that the aggregate price paid by the purchasers for the shares is less than the gross proceeds paid by the Canadian underwriters to us or the selling stockholders.

These shares are included in the net worth analysis and their value offset by a $ 624.3 million liability, the amount of borrowings against them, as disclosed in a March 2017 filing.

Amounts deducted and accumulated by the participant will be used to purchase shares of our Class A common stock at the end of each - month purchase period.

Upon exercise of a stock appreciation right, the holder of the award will be entitled to receive an amount determined by multiplying (i) the difference between the fair market value of a Share on the date of exercise over the exercise price by (ii) the number of exercised Shares.

Except in the event of the optionee's death, if the shares are disposed of prior to the expiration of the statutory holding periods (a «Disqualifying Disposition»), generally, the amount by which the fair market value of the shares at the time of exercise exceeds the total exercise price will be ordinary income.

Income sprinkling was typically accomplished by incorporating and issuing shares to a spouse and / or children, who could then be paid dividends in any amount in a given tax year.

In either case, for every share owned outside the program, either the existing shareholders or the chairman must give away, for free, a put option whose nominal amount is equal to the number of shares covered by the program divided by the number of shares not covered by the program.

«Total CEO realized compensation» for a given year is defined as (i) Mr. Musk's salary, cash bonuses, non-equity incentive plan compensation and all other compensation as reported in «Executive Compensation — Summary Compensation Table» below, plus (ii) with respect to any stock option exercised by Mr. Musk in such year in connection with which shares of stock were also sold other than to satisfy the resulting tax liability, if any, the difference between the market price of Tesla common stock at the time of exercise on the exercise date and the exercise price of the option, plus (iii) with respect to any restricted stock unit vested by Mr. Musk in such year in connection with which shares of stock were also sold other than automatic sales to satisfy the Company's withholding obligations related to the vesting of such restricted stock unit, if any, the market price of Tesla common stock at the time of vesting, plus (iv) any cash actually received by Mr. Musk in respect of any shares sold to cover tax liabilities as described in (ii) and (iii) above, following the payment of such amounts.

The EPS also rose drastically, by 45 %, which boosted dividend gains to $ 0.82 per share, or 2.17 % of the investment amount.

If Tesla goes ahead with its Tesla Mobility ride sharing business, the amount of data could rise to 400 million miles per day by 2025 or 2030.

Generally, if you paid a CDSC when you sold your shares, Franklin Templeton Distributors, Inc. (Distributors) will credit back to you the CDSC paid on the amount you are reinvesting within 90 days of the sale by adding it to the amount of your reinvestment (for example, if you are reinvesting $ 10,000 within 90 days of an earlier $ 10,000 sale on which you paid a $ 100 CDSC, the amount of your reinvestment will equal $ 10,100).

If at any time you so decide to opt - out by contacting us at the above email, RealtyShares will cease the sharing or use of your information after a reasonable amount of time to process such a request.

Dilution in pro forma net tangible book value per share to investors purchasing shares of our Class A common stock in this offering represents the difference between the amount per share paid by investors purchasing shares of our Class A common stock in this offering and the pro forma as adjusted net tangible book value per share of our Class A common stock immediately after completion of this offering.

Amounts deducted and accumulated by the participant will be used to purchase shares of our Class A common stock at the end of each purchase period.

Simply input a topic, keyword, or competitor, and BuzzSumo shows a list of posts ranked by the amount of social shares each receives.

This is equal in amount to the price on the convertible divided by the conversion ratio, the number of shares that the convertible convert.

Your amount realized will be measured by the sum of the cash or the fair market value of other property received plus your share under the partnership tax rules of our liabilities, if any.

This amount also includes 1,753,352 Shares deferred in the form of Shares by officers and Non-Management Directors.

Figure 1 shows this value - destroying behavior in action for GE (GE) by comparing between the amount of money spent buying back shares and the price to economic book value (PEBV), a measure of the growth expectations embedded in the stock price.

But prior to that these had been lax enough for vast amounts of personal data to be sucked out without most users being aware — because the data sharing was being «authorized» by their Facebook friends (who also likely weren't aware what they were agreeing to).

I've made some changes to the generated spreadsheet where the yearly dividend amount paid to you is now a formula calculated from the number of shares column multiplied by the annual dividend received by the stock column.

If we terminate Mr. Drexler's employment without cause or he terminates his employment with good reason, Mr. Drexler will be entitled to receive (i) a payment of his earned but unpaid annual base salary through the termination date, any accrued vacation pay and any un-reimbursed expenses, and (ii) subject to Mr. Drexler's execution of a valid general release and waiver of claims against us, as well as his compliance with the non-competition, non-solicitation and confidential information restrictions described below, (a) a payment equal to his annual base salary and target cash incentive award, one - half of such payment to be paid on the first business day that is six (6) months and one (1) day following the termination date and the remaining one - half of such payment to be paid in six equal monthly installments commencing on the first business day of the seventh calendar month following the termination date, (b) a payment equal to the product of (x) the last annual cash incentive award Mr. Drexler received prior to the termination date and (y) a fraction, the numerator of which is the number of days of service completed by Mr. Drexler in the year of termination and the denominator of which is 365, such amount to be paid on the first business day that is six (6) months and one (1) day following the termination date, and (c) the immediate vesting of such portion of unvested restricted shares and stock options as provided and pursuant to the terms of the relevant grant agreements under our 2003 Equity Incentive Plan.

However, the amount by which the fair market value of the shares at the time of exercise exceeds the option price will be an «item of adjustment» for participant for purposes of the alternative minimum tax.

Each Non-Management Director must own, within five years of his or her initial election or appointment to the Board, an amount of Shares, restricted stock, or stock units having a value equal to five times the annual retainer component of the Non-Management Director's compensation approved by the Board in the year the director was initially elected or appointed.

Except as expressly provided in the Plan, no issuance by J. Crew Group, Inc. of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number of shares or amount of other property subject to, or the terms related to, any Incentive Award.

The process of handing over control of specific business functions to a third party necessitates, by its very nature, a certain amount of data sharing.